| Patient | Elisabeth of Austria |
|---|---|
| Date of birth | 1969-12-24 |
| Identifiers | MRN HR-NI030-SYN; SSN (made up) 000-30-5817 |
| Document date | 2026-06-30 |
| Author | Adelheid Marchetti-Osei, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Twenty-one-week review: weight, mood, the gastroenteritis, and care while travelling. [S]
Empress Elisabeth returns five weeks after a gastroenteritis. The diarrhea settled within three days and she was back on her meal plan within the week, with no restriction afterwards. She did not have the blood test planned for two to three days after that visit, because she left to travel two days later and no laboratory was arranged. She has taken sertraline 50 mg daily. Her mood is better; she has had no thoughts of death. She walks about an hour a day and would like to return to some gymnastics. She leaves in a week to travel for six weeks, by sea and to her villa on the island, and asks how her care will continue while she is away. [S]
| Element | Detail |
|---|---|
| Gastroenteritis | Settled within three days; back on the meal plan |
| Missed test | Electrolytes planned two to three days after the sick visit not drawn |
| Mood | Better; PHQ-9 7; no thoughts of death |
| Travel | Leaves in a week for six weeks |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Energy good; no longer cold |
| Gastrointestinal | Negative | No diarrhea or vomiting |
| Cardiovascular | Negative | No swelling, palpitations or dizziness |
| Psychiatric | Negative | Mood better; no thoughts of death |
4 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Thiamine 100 mg tablet, one by mouth daily for 14 days, starting before the meal plan | once daily for 14 days | Oral route | 2026-02-03 to 2026-02-17 | completed | S |
| Cholecalciferol 50 microgram (2,000 IU) capsule, one by mouth daily | once daily | Oral route | 2026-02-03 | active | S |
| Potassium chloride 20 mEq extended-release tablet, one by mouth daily with food for three days | once daily for three days | Oral route | 2026-05-26 to 2026-05-28 | completed | S |
| Phosphorus 250 mg tablet (potassium and sodium phosphates), one by mouth twice daily with meals for three weeks | twice daily with meals | Oral route | 2026-02-10 to 2026-03-03 | completed | S |
| Calcium carbonate 1,250 mg (500 mg elemental calcium) tablet, one by mouth daily with a meal | once daily with a meal | Oral route | 2026-03-03 | active | S |
| Sertraline 25 mg tablet, one by mouth each morning for two weeks | once daily in the morning | Oral route | 2026-03-03 to 2026-03-17 | completed | S |
| Sertraline 50 mg tablet, one by mouth each morning | once daily in the morning | Oral route | 2026-03-17 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-06-30 | Body height | 172 | cm | S |
| 2026-06-30 | Body weight | 54 | kg | S |
| 2026-06-30 | Body mass index (BMI) [Ratio] | 18.3 | kg/m2 | S |
| 2026-06-30 | Systolic blood pressure | 106 | mm[Hg] | S |
| 2026-06-30 | Diastolic blood pressure | 68 | mm[Hg] | S |
| 2026-06-30 | Heart rate | 62 | /min | S |
| 2026-06-30 | Respiratory rate | 14 | /min | S |
| 2026-06-30 | Body temperature | 36.5 | Cel | S |
| 2026-06-30 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-06-30 | Sodium [Moles/volume] in Serum or Plasma | 138 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-06-30 | Potassium [Moles/volume] in Serum or Plasma | 4.1 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-06-30 | Magnesium [Mass/volume] in Serum or Plasma | 2 | mg/dL | 1.7-2.2 mg/dL | Normal | S |
| 2026-06-30 | Phosphate [Mass/volume] in Serum or Plasma | 3.6 | mg/dL | 2.5-4.5 mg/dL | Normal | S |
| 2026-06-30 | 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma | 34 | ng/mL | 30-100 ng/mL | Normal | S |
| 2026-06-30 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 7 | {score} | S |
Vital signs recorded on 2026-06-30; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Slim; weight 54.0 kg, BMI 18.3; temperature 36.5 C |
| Cardiovascular | Seated blood pressure 106/68, pulse 62; no orthostatic change; no edema |
| Psychiatric | Brighter; reactive affect; no intent or plan to harm herself |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Weight loss to a body mass index of 16.0 (47.4 kg at 172 cm), about 6 kg over six months, with fatigue, swelling of both ankles, dizziness on standing, slow pulse and cold intolerance; cause not established at intake; a restrictive eating disorder suspected, with thyroid disease, celiac disease, diabetes, malignancy and adrenal insufficiency to be excluded; eating disorders psychiatry consultation requested | resolved | confirmed | R63.4 | S — Synthetic presenting problem anchored to her documented restrictive eating, low weight and swelling; superseded by the diagnosis at the consultation. |
| Anorexia nervosa, restricting type, moderate (DSM-5-TR), with compulsive exercise and frequent self-weighing, beginning in early adulthood; complicated at diagnosis by sinus bradycardia, orthostatic dizziness, ankle edema, mild anemia and leukopenia, low glucose, raised ALT and low phosphate after refeeding began | active | confirmed | F50.011 | S — Synthetic modern diagnosis made at the consultation, linked to her documented restrictive eating and exercise and to the retrospective diagnosis of anorexia nervosa (R). |
| Major depressive disorder, recurrent, moderate, with persistent grief for her son, who died five years ago; passive thoughts of death without intent or plan at intake | active | confirmed | F33.1 | S — Synthetic modern diagnosis linked to her documented mourning and ever-deepening depressions; not a claim that she was so diagnosed. |
| Acute viral gastroenteritis, caught from a member of her travelling party, with mild dehydration, orthostatic hypotension and mild hypokalemia; no purging behavior; managed with oral rehydration and potassium; resolved | resolved | confirmed | A08.4 | S — Synthetic acute problem; not a historical claim. |
| Low bone mass (osteopenia) of the lumbar spine and hip after decades of low weight: lumbar spine T-score -2.1, femoral neck T-score -1.8; FRAX 10-year probabilities 6.8% for a major osteoporotic fracture and 1.2% for hip fracture; no fractures | active | confirmed | M85.80 | S — Synthetic modern finding on DXA; not a historical claim. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Weight and BMI (open weighing in the consulting room) | Weekly at first, then every visit | Completed today | 54.0 kg, BMI 18.3; up 6.6 kg since intake |
| Examination | Orthostatic pulse and blood pressure, and temperature | Every visit | Completed today | Pulse 62, blood pressure 106/68, no orthostatic change; temperature 36.5 C |
| Laboratory | Sodium, potassium, phosphate, magnesium and glucose | Baseline; three to four days after nutrition starts; weekly for the first weeks; then at each visit while underweight | Completed today | Sodium 138, potassium 4.1 mmol/L, phosphate 3.6 mg/dL, magnesium 2.0 mg/dL. Protocol deviation: the electrolytes and magnesium planned for two to three days after the sick visit, when potassium was 3.3 mmol/L, were not drawn, because she left to travel and no laboratory had been arranged. No harm resulted: she took the three days of potassium, the illness settled, and today's results are normal. Corrective action: when a recheck is needed before she travels, it is drawn before she leaves or booked at a laboratory where she will be |
| Laboratory | 25-hydroxyvitamin D after repletion | About three months after starting, then yearly | Completed today | 34 ng/mL on 2,000 IU daily |
| Examination | Refeeding edema and signs of heart failure | Every visit | Completed today | No edema |
| Self-management | Exercise and compulsive activity | Every visit | Completed today | About an hour of walking a day; graded return agreed: stretching twice a week, walks up to 90 minutes |
| Self-management | Multidisciplinary treatment: CBT-E attendance, dietitian, psychiatry | Weekly therapy; dietitian every two weeks | Completed today | Weekly CBT-E and dietitian attended; video sessions arranged for the journey |
| Survey | PHQ-9 | At least monthly during acute treatment; every 2 to 4 weeks in continuation | Completed today | 7, a 56 percent fall from 16 |
| Survey | Suicide risk reassessment (C-SSRS Since Last Visit and PHQ-9 item 9) | Every visit | Completed today | No thoughts of death since the last visit; PHQ-9 item 9 scored 0. Safety plan updated for travel |
| Medication safety | Adherence and adverse-effect review | Every visit | Completed today | No missed doses, including during the gastroenteritis; no side effects |
| Imaging | DXA of the spine and hip | Every two years | Up to date | Low bone mass four months ago; repeat in two years |
Goal progress:
Immunizations given today: Recombinant zoster vaccine, dose 2 of 2 [S]
Guideline basis: The American Psychiatric Association Practice Guideline for the Treatment of Patients With Eating Disorders, Fourth Edition (2023); Medical Management of Restrictive Eating Disorders in Adolescents and Young Adults (position paper) (2022); Eating Disorders: A Guide to Medical Care (AED Medical Care Standards Guide), 4th edition (2021); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders and osteoporosis monographs (2026); VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024)
Follow-up: Weekly video therapy while away. Review on her return in about six weeks. [S]